Up a level |
Jump to: 2014
Number of items: 1.
2014
Haber, M., Murray, J., Gamble, L., Carnegie-Clark, A., Webber, H., Ruhle, M., Carter, D., Oberthur, A., Fischer, M., Ziegler, D., Marshall, G. M., Gurova, K., Burkhart, C., Purmal, A., Gudkov, A. V. and Norris, M. D. (2014). CBL0137, a novel NFkB suppressor and p53 activator, is highly effective in pre-clinical models of neuroblastoma. Eur. J. Cancer, 50. S. 135 - 136. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852